文献速递瓣膜病与结构性心脏病

无症状重度主动脉瓣狭窄患者的B型利钠肽预后价值

B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
PubMed 文献 · Heart · 2018-12-07

基于日本多中心CURRENT AS注册研究387例未转诊AVR的无症状重度AS且左室功能正常患者,按BNP水平分组,发现BNP升高与AS相关事件风险递增相关,BNP<100 pg/mL者1年事件率仅2.1%。

要点

  • 无症状重度AS且LVEF正常未转诊AVR者,BNP升高与AS相关事件风险递增相关。
  • BNP<100 pg/mL者5年事件率14.2%,1年事件率仅2.1%,可安全观察等待。
  • BNP>300 pg/mL者5年事件率47.0%,调整后HR 7.38,风险显著增高。

核心结论

  • 在未转诊AVR的无症状重度AS且左室射血分数正常的患者中,BNP水平升高与AS相关不良事件风险增高相关。
  • BNP<100 pg/mL的无症状患者事件率相对较低,可能可安全采用观察等待策略。

研究设计与样本

  • 基于日本多中心注册研究CURRENT AS,纳入3815例连续重度AS患者。

主要发现

  • AS相关事件(主动脉瓣相关死亡或心衰住院)5年累积发生率随BNP升高递增:14.2%、29.6%、46.3%、47.0%(p<0.001)。
  • BNP<100 pg/mL的无症状患者1年事件率仅2.1%。

关键数值与推荐

  • BNP分组阈值:<100 pg/mL、100≤BNP<200 pg/mL、200≤BNP<300 pg/mL、BNP>300 pg/mL。
  • 主要终点为AS相关事件,包括主动脉瓣相关死亡或心衰住院。
  • 5年累积事件率分别为14.2%、29.6%、46.3%、47.0%(p<0.001)。

临床怎么用

  • 对无症状重度AS且LVEF正常、未转诊AVR的患者,可检测BNP进行风险分层。
  • BNP<100 pg/mL者1年事件率低,可考虑观察等待策略并定期随访。
  • BNP升高(尤其>300 pg/mL)提示AS相关事件风险显著增加,应加强监测并重新评估AVR时机。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We sought to evaluate the prognostic impact of the B-type natriuretic peptide (BNP) levels in patients with asymptomatic severe aortic stenosis (AS), who were not referred for aortic valve replacement (AVR). METHODS: We used data from a Japanese multicentre registry, the Contemporary outcomes after sURgery and medical tREatmeNT in patients with severe Aortic Stenosis Registry, which enrolled 3815 consecutive patients with severe AS. Of those, 387 asymptomatic patients who were not referred for AVR without left ventricular dysfunction and very severe AS were subdivided into four groups based on their BNP levels (BNP<100 pg/mL, n=201; 100≤BNP<200 pg/mL, n=94; 200≤BNP<300 pg/mL, n=42 and BNP>300 pg/mL, n=50). RESULTS: The cumulative 5-year incidence of AS-related events (aortic valve-related death or heart failure hospitalisation) was incrementally higher with increasing BNP level (14.2%, 29.6%, 46.3% and 47.0%, p<0.001). After adjusting for confounders, the risk for AS-related events was incrementally greater with increasing BNP levels (HR: 1.97, 95% CI: 0.97 to 3.98, p=0.06; HR: 3.59, 95% CI: 1.55 to 8.32, p=0.03 and HR: 7.38, 95% CI: 3.21 to 16.9, p<0.001, respectively). Notably, asymptomatic patients with BNPlevels of <100 pg/mL had an event rate of only 2.1% at 1 year. CONCLUSIONS: Increased BNP level was associated with a higher risk for AS-related adverse events in patients with asymptomatic severe AS with normal left ventricular ejection fraction who were not referred for AVR. Asymptomatic patients with BNP levels of <100 pg/mL had relatively low event rate, who might be safely followed with watchful waiting strategy. TRAIL REGISTRATION NUMBER: UMIN000012140.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Nakatsuma K, Taniguchi T, Morimoto T, et al. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis. Heart. 2018. PMID: 30530820. doi:10.1136/heartjnl-2018-313746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。